These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37809067)

  • 1. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
    Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
    Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL.
    Martínez LE; Lensing S; Chang D; Magpantay LI; Mitsuyasu R; Ambinder RF; Sparano JA; Martínez-Maza O; Epeldegui M
    Sci Rep; 2022 Jun; 12(1):9185. PubMed ID: 35655072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
    Serratì S; Guida M; Di Fonte R; De Summa S; Strippoli S; Iacobazzi RM; Quarta A; De Risi I; Guida G; Paradiso A; Porcelli L; Azzariti A
    Mol Cancer; 2022 Jan; 21(1):20. PubMed ID: 35042524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unique B-cell populations in the circulation of people living with HIV prior to non-Hodgkin lymphoma diagnosis.
    Martínez LE; Comin-Anduix B; Güemes-Aragon M; Ibarrondo J; Detels R; Mimiaga MJ; Epeldegui M
    Front Immunol; 2024; 15():1441994. PubMed ID: 39324141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
    Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
    Sci Rep; 2019 Jun; 9(1):9371. PubMed ID: 31253857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma.
    Li JW; Shi D; Wan XC; Hu J; Su YF; Zeng YP; Hu ZJ; Yu BH; Zhang QL; Wei P; Zhou XY
    Oncoimmunology; 2021; 10(1):1995166. PubMed ID: 34745768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of the PD-1/PD-L1 pathway in AIDS-related non-Hodgkin lymphoma.
    Zhao H; Cai S; Xiao Y; Xia M; Chen H; Xie Z; Tang X; He H; Peng J; Chen J
    Cancer Med; 2024 Apr; 13(7):e7195. PubMed ID: 38613207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles  produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis.
    He H; Chen Q; Fan H; Leng XY; Zhu F; Gao F; Zhou Q; Dong Y; Yang J
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2243-2254. PubMed ID: 36044618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles.
    Khan A; Di K; Khan H; He N; Li Z
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
    Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
    AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of T-cell-suppressive PD-L1
    Baur R; Karl F; Böttcher-Loschinski R; Stoll A; Völkl S; Gießl A; Flamann C; Bruns H; Schlötzer-Schrehardt U; Böttcher M; Schewe DM; Fischer T; Jitschin R; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36898735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
    Liang Y; Liu Y; Zhang Q; Zhang H; Du J
    Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis.
    Zeng Q; Liu Z; Liu T
    BMC Cancer; 2020 Jan; 20(1):59. PubMed ID: 31992262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Analysis in Oral Cancer Immunotherapy: Profiling Dual PD-L1-Positive Extracellular Vesicle Subtypes with Step-Wedge Microfluidic Chips.
    Yu ZL; Wu ZY; Liu XC; Ji CX; Wang X; Fu QY; Chen G; Wu M; Hong SL; Jia J
    Anal Chem; 2024 Sep; 96(37):14980-14988. PubMed ID: 39235216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.